[ET Net News Agency, 1 April 2026] INNOCARE (09969) rose 10% to HK$14.91.
It hits an intra-day high of HK$14.93, hitting an 1-month high, breaking above the 250-D
SMA of HK$13.759, and an intra-day low of HK$13.77. The total shares traded was 9.97
million, with a value of HK$143.52m. The active buy/sell ratio is 75:25, with net buying
turnover of HK$69.74m. HSBC SEC BRO (ASIA) accounts for greatest net responsive buying
turnover of HK$1.8m, with volume weighted average price of HK$14.315. CHINA INV INFO
accounts for greatest net responsive selling turnover of HK$18.32m, with volume weighted
average price of HK$14.406.

Basic Information
=================

----------------------------------
Nominal 14.910 % Chg +9.96%
High 14.930 Low 13.770
Shares Tr 9.97m Turnover 143.52m
10-D SMA 12.846 %H.V 43.766
20-D SMA 12.391 VWAP 14.402
50-D SMA 12.183 RSI14 73.667
----------------------------------
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is
75:25, with net buying turnover of HK$69.74m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
INNOCARE (09969) 14.91 +9.96
INNOVENT BIO (01801) 90.45 +6.54
KEYMED BIO-B (02162) 67.40 +11.04
XTALPI (02228) 9.57 +6.22
WUXI XDC (02268) 61.05 +4.90
WUXI BIO (02269) 34.96 +5.88
WUXI APPTEC (02359) 123.30 +4.94
BEONE MEDICINES (06160) 184.50 +7.52
AKESO (09926) 139.40 +7.07
REMEGEN (09995) 109.60 +14.40
-----------------------------------------------
(ed)